Brief: Valeo Pharma Announces Filing Of New Drug Submission For Low Molecular Weight Heparin In Canada
14/11/2019 11:18
Nov 14 (Reuters) - Valeo Pharma Inc VPH.CD :
* VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION FOR
LOW
MOLECULAR WEIGHT HEPARIN IN CANADA
Source text for Eikon: ID:nCNWzDWVwa
Further company coverage: VPH.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada